D.E. Shaw & Co
FLNA

D.E. Shaw & Co’s Filana Therapeutics FLNA Stock Holding History

D.E. Shaw & Co’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$295K – 4812
2022
Q4 		$295K Hold
10,000
– – ﹤0.01% 4094
2022
Q3 		$418K Hold
10,000
– – ﹤0.01% 4137
2022
Q2 		$281K Hold
10,000
– – ﹤0.01% 4391
2022
Q1 		$371K Hold
10,000
– – ﹤0.01% 4541
2021
Q4 		$437K Hold
10,000
– – ﹤0.01% 4474
2021
Q3 		$621K Hold
10,000
– – ﹤0.01% 3951
2021
Q2 		$854K Buy
+10,000
New +$536K ﹤0.01% 3673

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co's FLNA Position: Q1 2026 in Review

D.E. Shaw & Co increased its Filana Therapeutics (FLNA) stake by 19% in Q1 2026, buying an estimated $185K and bringing the position to 559,205 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.

D.E. Shaw & Co first reported a position in FLNA in Q2 2013 and has held it in 29 quarters since. The position peaked at $5.13M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • D.E. Shaw & Co held 559,205 shares of Filana Therapeutics worth $945K as of Q1 2026.
  • D.E. Shaw & Co bought 89,879 Filana Therapeutics shares in Q1 2026, an estimated $185K.
  • Filana Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3483 holding.
  • D.E. Shaw & Co first reported a position in Filana Therapeutics in Q2 2013 and has held it in 29 quarters since.
  • D.E. Shaw & Co's Filana Therapeutics position peaked at $5.13M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.